These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 1978496)
1. A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial. Lapierre YD; Nair NP; Chouinard G; Awad AG; Saxena B; Jones B; McClure DJ; Bakish D; Max P; Manchanda R Acta Psychiatr Scand Suppl; 1990; 358():72-7. PubMed ID: 1978496 [TBL] [Abstract][Full Text] [Related]
2. A double-blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia. Laux G; Klieser E; Schröder HG; Dittmann V; Unterweger B; Schubert H; König P; Schöny HW; Bunse J; Beckmann H Acta Psychiatr Scand Suppl; 1990; 358():125-9. PubMed ID: 1978471 [TBL] [Abstract][Full Text] [Related]
3. A double-blind comparative multicentre study of remoxipride and haloperidol in schizophrenia. Lindström LH; Wieselgren IM; Struwe G; Kristjansson E; Akselson S; Arthur H; Andersen T; Lindgren S; Norman O; Naimell L Acta Psychiatr Scand Suppl; 1990; 358():130-5. PubMed ID: 1978472 [TBL] [Abstract][Full Text] [Related]
4. A double-blind multicentre comparison of remoxipride, at two dose levels, and haloperidol. Patris M; Agussol P; Alby JM; Brion S; Burnat G; Castelnau D; Deluermoz S; Dufour H; Ferreri M; Goudemand M Acta Psychiatr Scand Suppl; 1990; 358():78-82. PubMed ID: 1978497 [TBL] [Abstract][Full Text] [Related]
5. A double-blind multicentre study comparing remoxipride, controlled release formulation, with haloperidol in schizophrenia. Pflug B; Bartels M; Bauer H; Bunse J; Gallhofer B; Haas S; Kanzow WT; Klieser E; Küfferle B; Stein D Acta Psychiatr Scand Suppl; 1990; 358():142-6. PubMed ID: 1978475 [TBL] [Abstract][Full Text] [Related]
6. Experiences of long-term treatment with remoxipride: efficacy and tolerability. Wålinder J; Holm AC Acta Psychiatr Scand Suppl; 1990; 358():158-63. PubMed ID: 1978477 [TBL] [Abstract][Full Text] [Related]
7. Remoxipride and haloperidol in the acute phase of schizophrenia: a double-blind comparison. Deo R; Soni S; Rastogi SC; Levine S; Plant I; Edwards JG; Mitchell M; Chanas A Acta Psychiatr Scand Suppl; 1990; 358():120-4. PubMed ID: 1978470 [TBL] [Abstract][Full Text] [Related]
17. Plasma concentration of remoxipride in relation to antipsychotic effect and adverse symptoms. The Canadian Remoxipride Study Group. Jostell KG; Lapierre YD Acta Psychiatr Scand Suppl; 1990; 358():48-50. PubMed ID: 1978488 [TBL] [Abstract][Full Text] [Related]
18. A double-blind comparative study of remoxipride and haloperidol in schizophrenic and schizophreniform disorders. Mendlewicz J; de Bleeker E; Cosyns P; Deleu G; Lotstra F; Masson A; Mertens C; Parent M; Peuskens J; Suy E Acta Psychiatr Scand Suppl; 1990; 358():138-41. PubMed ID: 1978474 [TBL] [Abstract][Full Text] [Related]
19. Comparison of sensorimotor and cognitive performance of acute schizophrenic inpatients treated with remoxipride or haloperidol. Classen W; Laux G Neuropsychobiology; 1989; 21(3):131-40. PubMed ID: 2575719 [TBL] [Abstract][Full Text] [Related]
20. Atypical neuroleptics in acute schizophrenia: a double-blind comparative study of remoxipride and haloperidol. den Boer JA; Westenberg HG Psychopharmacol Bull; 1990; 26(1):99-107. PubMed ID: 1973547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]